Selenium sulfide
Selenium Sulfide (selenium sulfide) is a small molecule pharmaceutical. Selenium sulfide was first approved as Selsun on 1982-01-01. It is used to treat dandruff, deficiency diseases, scalp dermatoses, seborrheic dermatitis, and tinea capitis amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| amazon basics maximum strength dandruff | C200263 | 2024-02-26 |
| anti dandruff | C200263 | 2023-12-21 |
| antidandruff | OTC monograph final | 2010-08-05 |
| care one | OTC monograph final | 2013-07-15 |
| careone | OTC monograph final | 2015-01-14 |
| careone medicated dandruff | OTC monograph final | 2022-11-22 |
| careone medicated dandruff with menthol | OTC monograph final | 2018-03-28 |
| careone moisturizing dandruff with aloe | OTC monograph final | 2018-03-28 |
| cvs health maximum strength dandruff | C200263 | 2024-09-24 |
| cvs pharmacy | OTC monograph final | 2017-07-19 |
Show 57 more
Indications
FDA
EMA
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
5 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Recurrence | D012008 | — | — | — | — | — | 1 | — | 1 |
| Tinea versicolor | D014010 | EFO_0007439 | B36.0 | — | — | — | 1 | — | 1 |
| Pityriasis | D010915 | — | — | — | — | — | 1 | — | 1 |
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dandruff | D063807 | — | L21.0 | — | — | — | — | 2 | 2 |
| Dermatitis | D003872 | HP_0011123 | L30.9 | — | — | — | — | 1 | 1 |
| Seborrheic dermatitis | D012628 | HP_0001051 | L21 | — | — | — | — | 1 | 1 |
| Scalp dermatoses | D012536 | — | — | — | — | — | — | 1 | 1 |
| Tinea | D014005 | EFO_0007510 | B35.9 | — | — | — | — | 1 | 1 |
| Tinea capitis | D014006 | — | B35.0 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Selenium sulfide |
| INN | — |
| Description | Selenium sulfide is a sulfide salt. |
| Classification | Small molecule |
| Drug class | quaternary ammonium derivatives |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | S=[Se]=S |
Identifiers
| PDB | — |
| CAS-ID | 7488-56-4 |
| RxCUI | 36345 |
| ChEMBL ID | CHEMBL1200680 |
| ChEBI ID | — |
| PubChem CID | 24087 |
| DrugBank | DB00971 |
| UNII ID | — |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Selenium sulfide
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 499 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
771 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use